You should not use GLP-1 medications if you have: Personal or family history of medullary thyroid cancer Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous severe allergic reaction to semaglutide or liraglutide Current pregnancy or planning to become pregnant History of pancreatitis (requires careful evaluation) Severe gastrointestinal disease Additionally, these medications are not typically recommended for patients under 18 years old, though Saxenda has some pediatric approval for adolescents 12 and older with obesity
So what do these look like exactly
Stay consistent with lifestyle changes while working with your doctor to achieve your health goals
That additional 7-14 percentage points over semaglutide comes from the glucagon receptor activation, which drives increased energy expenditure through a mechanism that the other two peptides simply do not have
Supports appetite regulation and metabolic balance GLP-1/GIP care for appetite regulation and metabolic balance Talk with our team and learn more before you begin GLP-1 microdosing uses a low weekly dose to help support appetite regulation and metabolic balance
You can read the abstract at Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A group of researchers conducted a phase 3 clinical trial to examine the efficacy and safety of subcutaneous semaglutide 2.4 mg once per week, semaglutide 1.0 mg (licensed for the treatment of diabetes), and placebo in managing weight in an adult population who were overweight or obese and have type 2 diabetes